9. Results of sensitivity network meta‐analysis for the outcome mortality (low risk of bias). Prediction intervals. Treatments are ordered by P‐score (descending). Only subnetworks with > 1 design.
95% prediction intervals (risk ratios, random‐effects model) | ||||
Zoledronic acid | [ 0.84, 1.25 ] | [ 0.84, 1.36 ] | [ 0.29, 4.15 ] | [ 0.92, 1.4 ] |
[ 0.8, 1.19 ] | Denosumab | [ 0.76, 1.42 ] | [ 0.28, 4.09 ] | [ 0.83, 1.48 ] |
[ 0.74, 1.19 ] | [ 0.71, 1.31 ] | Clodronate | [ 0.28, 3.84 ] | [ 0.94, 1.21 ] |
[ 0.24, 3.42 ] | [ 0.24, 3.56 ] | [ 0.26, 3.61 ] | Risedronate | [ 0.28, 3.82 ] |
[ 0.71, 1.08 ] | [ 0.68, 1.21 ] | [ 0.83, 1.07 ] | [ 0.26, 3.59 ] | No treatment/placebo |